Press Releases
- Alnylam Reports Positive Initial Clinical Results for ALN-CC5, an Investigational RNAi Therapeutic Targeting Complement Component C5 for the Treatment of Complement-Mediated Diseases
- LEERINK Capital Partners and Revelation Partners Announce Strategic Partnership and Close of $192 Million Healthcare Fund Business Wire LEERINK Partners LLC
- AVEO Announces FDA Update for Tivozanib in Colorectal Cancer
- Synthetic Genomics and Gen9 Sign Licensing Agreement for Synthetic Biology Technology Patents
- FDA Failures Result in Wider Approval of Orphan Medication for Sleep Disorder
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.

